UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Melatonin: A Molecule for Reducing Breast Cancer Risk

Molecules (Basel, Switzerland), 2018-02, Vol.23 (2), p.336

2018

Volltextzugriff (PDF)

Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders

Current medicinal chemistry, 2017-11, Vol.24 (35), p.3851

2017

Volltextzugriff (PDF)

Melatonin inhibits the growth of DMBA‐induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity

International journal of cancer, 2006-01, Vol.118 (2), p.274-278

2006

Volltextzugriff (PDF)

Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation

Expert opinion on investigational drugs, 2012-06, Vol.21 (6), p.819-831

2012

Volltextzugriff (PDF)

Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats

Cancer letters, 2006-04, Vol.235 (2), p.266-271

2006

Volltextzugriff (PDF)

Clinical Uses of Melatonin in Pediatrics

International Journal of Pediatrics, 2011-01, Vol.2011 (2011), p.263-273

2011

Volltextzugriff (PDF)

Estrogen-signaling pathway: A link between breast cancer and melatonin oncostatic actions

Cancer detection and prevention, 2006-01, Vol.30 (2), p.118-128

2006

Volltextzugriff (PDF)

Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells

Breast cancer research and treatment, 2005-12, Vol.94 (3), p.249-254

2005

Volltextzugriff (PDF)

Melatonin down-regulates hTERT expression induced by either natural estrogens (17β-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells

Cancer letters, 2008-09, Vol.268 (2), p.272-277

2008

Volltextzugriff (PDF)

Role of melatonin in the epigenetic regulation of breast cancer

Breast cancer research and treatment, 2009-05, Vol.115 (1), p.13-27

2009

Volltextzugriff (PDF)

Breast Cancer Therapy Based on Melatonin

Recent patents on endocrine, metabolic & immune drug discovery, 2012-05, Vol.6 (2), p.108-116

2012

Volltextzugriff (PDF)

Smith-magenis syndrome : A case report of improved sleep after treatment with β1-adrenergic antagonists and melatonin

The Journal of pediatrics, 2006-09, Vol.149 (3), p.409-411

2006

Volltextzugriff (PDF)

Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa)

Toxicology letters, 2008-10, Vol.181 (3), p.190-195

2008

Volltextzugriff (PDF)

Recent patents on light based therapies: photodynamic therapy, photothermal therapy and photoimmunotherapy

Recent patents on endocrine, metabolic & immune drug discovery, 2014-01, Vol.8 (1), p.1-8

2014

Volltextzugriff (PDF)

Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of D own syndrome

Journal of pineal research, 2014-01, Vol.56 (1), p.51-61

2014

Volltextzugriff (PDF)

Long‐term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle‐aged T s65 D n mice, a model of D own syndrome

Journal of pineal research, 2013-04, Vol.54 (3), p.346-358

2013

Volltextzugriff (PDF)

Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells

Cancer research (Chicago, Ill.), 1998-10, Vol.58 (19), p.4383-4390

1998

Volltextzugriff (PDF)

In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin

Current cancer drug targets, 2010-05, Vol.10 (3), p.279-286

2010

Volltextzugriff (PDF)

Constitutive photomorphogenesis protein 1 ( COP 1) and COP 9 signalosome, evolutionarily conserved photomorphogenic proteins as possible targets of melatonin

Journal of pineal research, 2016-08, Vol.61 (1), p.41-51

2016

Volltextzugriff (PDF)

Melatonin, experimental basis for a possible application in breast cancer prevention and treatment

Histology and histopathology, 2000-04, Vol.15 (2), p.637

2000

Volltextzugriff (PDF)

Scientific Basis for the Potential Use of Melatonin in Bone Diseases: Osteoporosis and Adolescent Idiopathic Scoliosis

Journal of Osteoporosis, 2010, Vol.2010 (2010), p.139-148

2010

Volltextzugriff (PDF)

Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists

Recent patents on endocrine, metabolic & immune drug discovery, 2007-06, Vol.1 (2), p.142-151

2007

Volltextzugriff (PDF)

Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin

The Journal of pediatrics, 2006-09, Vol.149 (3), p.409

2006

Volltextzugriff (PDF)

Smith-Magenis syndrome: A case report of improved sleep after treatment with β 1-adrenergic antagonists and melatonin

The Journal of pediatrics, 2006, Vol.149 (3), p.409-411

2006

Volltextzugriff (PDF)

Clinical uses of melatonin: evaluation of human trials on cancer treatment

Melatonin Research, 2019-06, Vol.2 (2), p.47-69

2019

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Melatonin: A Molecule for Reducing Breast Cancer Risk

Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders

Melatonin inhibits the growth of DMBA‐induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity

Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation

Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats

Clinical Uses of Melatonin in Pediatrics

Estrogen-signaling pathway: A link between breast cancer and melatonin oncostatic actions

Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells

Melatonin down-regulates hTERT expression induced by either natural estrogens (17β-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells

Role of melatonin in the epigenetic regulation of breast cancer

Breast Cancer Therapy Based on Melatonin

Smith-magenis syndrome : A case report of improved sleep after treatment with β1-adrenergic antagonists and melatonin

Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa)

Recent patents on light based therapies: photodynamic therapy, photothermal therapy and photoimmunotherapy

Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of D own syndrome

Long‐term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle‐aged T s65 D n mice, a model of D own syndrome

Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells

In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin

Constitutive photomorphogenesis protein 1 ( COP 1) and COP 9 signalosome, evolutionarily conserved photomorphogenic proteins as possible targets of melatonin

Melatonin, experimental basis for a possible application in breast cancer prevention and treatment

Scientific Basis for the Potential Use of Melatonin in Bone Diseases: Osteoporosis and Adolescent Idiopathic Scoliosis

Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists

Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin

Smith-Magenis syndrome: A case report of improved sleep after treatment with β 1-adrenergic antagonists and melatonin

Clinical uses of melatonin: evaluation of human trials on cancer treatment

Aktive Filter

Suchergebnisse filtern